1. Home
  2. PASG vs ATCX Comparison

PASG vs ATCX Comparison

Compare PASG & ATCX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

PASG

Passage Bio Inc.

HOLD

Current Price

$4.08

Market Cap

26.0M

Sector

Health Care

ML Signal

HOLD

ATCX

Atlas Critical Minerals Corporation Common Stock

N/A

Current Price

$5.87

Market Cap

23.8M

Sector

N/A

ML Signal

N/A

Company Overview

Basic Information
Metric
PASG
ATCX
Founded
2017
2016
Country
United States
Brazil
Employees
27
13
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
26.0M
23.8M
IPO Year
2020
N/A

Fundamental Metrics

Financial Performance
Metric
PASG
ATCX
Price
$4.08
$5.87
Analyst Decision
Buy
Strong Buy
Analyst Count
7
1
Target Price
$14.00
$13.75
AVG Volume (30 Days)
129.1K
38.5K
Earning Date
05-12-2026
03-16-2023
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
$827,667.00
Revenue Next Year
N/A
$166.45
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.28
$4.39
52 Week High
$20.00
$14.01

Technical Indicators

Market Signals
Indicator
PASG
ATCX
Relative Strength Index (RSI) 29.13 56.36
Support Level N/A $4.66
Resistance Level $8.94 $6.46
Average True Range (ATR) 0.61 0.36
MACD -0.31 0.09
Stochastic Oscillator 2.35 83.04

Price Performance

Historical Comparison
PASG
ATCX

About PASG Passage Bio Inc.

Passage Bio Inc is a clinical-stage genetic medicines company focused on improving the lives of patients with neurodegenerative diseases. Their primary focus is the development and advancement of cutting-edge, one-time gene therapies designed to target critical underlying pathologies in these conditions. The Company operates in a single reportable segment, developing and advancing genetic medicines designed to target the critical underlying pathology of neurodegenerative diseases. The pipeline having PBFT02.

About ATCX Atlas Critical Minerals Corporation Common Stock

Atlas Critical Minerals Corp is a mineral exploration and development company focused on critical minerals projects and properties in Brazil. The company's portfolio principally includes mineral properties for rare earths, graphite, titanium, copper, uranium, and nickel. It also owns mineral rights for iron ore, quartzite, gold, and diamond properties. The company's project portfolio includes the Alto Paranaiba, Malacacheta, Arcos, Goias, Tocantins, Rio Piracicaba, and other projects.

Share on Social Networks: